Unsubscribe

A message from our friends at Porter & Company

My name is Porter Stansberry. 

I’m the founder of one of the largest financial research firms in the world. Over the last 26 years we’ve helped investors navigate almost every major economic cycle. 

We’ve also been on the forefront of every big financial story from the rise of Bitcoin and MRNA vaccines to robotics and artificial intelligence – just to name a few. 

But today, I’m breaking the biggest story of my career…

An economic story the likes of which we’ve not seen in centuries. In fact, the last – and only time – this happened was in 1776. But now, on the eve of America’s 250th anniversary, it’s happening again. 

And as you’ll discover today, the aftershock of this event could “reset” not just your personal wealth, but the entire U.S. economic system: 

How you work, how you vote, how you protect and build your wealth… it’s all being turned upside down by what one famous Stanford economist says is: 

“The biggest change ever… bigger than electricity… bigger than the steam engine.” 

Yet almost nobody is prepared for it. So, if you’ve been watching the chaos of the past year unfold, struggling to understand what it all means… you’re about to get many – if not all – of the answers you’ve been searching for.

And, most importantly, what it all means for you, your money, and your investment portfolio in the months ahead 

Because as you’ll discover, everything from the government taking stakes in companies like Intel, Lithium Americas, and MP Materials.

To Trump’s strike on Venezuela… his deal with Greenland… his seemingly never-ending slew of executive orders… and increasingly centralized grip over the economy… 

All the way to the surging popularity of radical socialist politicians like Bernie Sanders, AOC, and Zohran Mamdani… 

It’s all deeply and inexorably intertwined in what is, without a doubt, the most consequential story of the year. 

A turning point that one Nobel Prize winner says is dividing not just the economy but our entire society.

And, as my guest and I explain, the financial decisions you make in the face of this New 1776 Moment… they could dictate whether you’re enriched, left stuck in the past, or potentially even impoverished by the seismic changes barreling down upon America.

The stocks to buy… the stocks to sell… and the three money moves to ensure you and your loved ones end up on the winning side of this new economic reality. 

It’s all laid out here for you…

Good investing, 

Porter Stansberry

---

Featured Story from MarketBeat

3 Stocks Under $5 With Strong Analyst Upside Potential

Written by Chris Markoch. Originally Published: 2/24/2026. 

Key Points

• Grab Holdings is gaining analyst support as revenue growth and its first full year of profitability highlight long-term opportunity in Southeast Asia’s expanding digital economy.
• Vaxart offers speculative biotech upside with its oral vaccine platform targeting influenza, norovirus, and COVID-19, creating a high-risk, high-reward setup.
• ThredUp is positioned to benefit from the fast-growing resale market, with strong institutional ownership and industry forecasts pointing to sustained secondhand demand.
• Special Report: Introducing “Elon Musk’s Day-One Retirement Plan”(From Brownstone Research)

While many investors are rotating out of speculative penny stocks, others still embrace their risk-reward profile. Stocks trading under $5 carry significant risk: many are unprofitable, and some generate little to no revenue.

In almost every case these are small-cap companies, a sector that has been beaten up in recent years. Even though the Russell 2000 has shown some signs of growth, that strength hasn’t been widespread across the broader small-cap universe.

Have $500? Invest in Elon’s AI Masterplan (Ad)

What if you could claim a stake in what’s set to be the biggest IPO ever… starting with just $500?

Everyone is talking about Elon Musk’s SpaceX IPO.Click here to get the details and I’ll show you how to claim your stake…

That could change in 2026 if the economic outlook improves and money begins flowing back into speculative names. As always, quality matters.

One way to filter for quality is to look for names with positive analyst sentiment. That’s true of the three stocks below. Each lets investors establish a meaningful position with a modest amount of capital while retaining the potential for significant upside over the next five years.

Profitability Milestone Meets Long-Term Emerging Market Growth

Emerging-market stocks are expected to be among the winners in 2026, but that hasn’t been the case so far for Grab Holdings Inc. (NASDAQ: GRAB), which is down about 15% year-to-date. Based in Singapore, Grab operates a “super app” that combines ride-hailing, e-commerce and fintech services.

One reason for the recent pullback is its proposed merger with Indonesian ride-hailing competitor GoTo. The deal is not final and could be affected by Indonesian regulatory changes that might limit the combined company’s earnings potential in that market.

Grab missed slightly on the top line in its Q4 2025 earnings report, but context matters: revenue rose 19% year-over-year, and the year marked the company’s first full-year profitability. Analysts are forecasting roughly 120% earnings growth over the next 12 months.

That helps explain continued bullish sentiment. GRAB stock has a consensus price target of $6.47, about 54% above the current price.

High-Risk Biotech With Platform Potential

Biotech often attracts penny-stock investors seeking high upside. One company to watch is Vaxart Inc. (OTCMKTS: VXRT), the only name on this list that fits the classic penny-stock definition — trading slightly above $0.60 per share at the time of writing.

Analyst coverage is light: the lone analyst to rate VXRT in the past 12 months has a Buy rating and a $2 price target.

Because Vaxart is a clinical-stage company, all of its candidates remain in trials, which often leads to sparse analyst coverage.

The upside is clear: Vaxart develops oral vaccines targeting influenza, norovirus and COVID-19.

Besides convenience and avoiding needle anxiety, Vaxart says its oral platform can elicit a broader immune response that may confer wider protection.

Institutional ownership is low — roughly 18% — but dollar-volume data show inflows outnumbering outflows by nearly 10:1.

Resale Tailwinds Could Turn Today’s Losses Into Tomorrow’s Gains

ThredUp Inc. (NASDAQ: TDUP) is down about 33% in 2026, but a longer view shows TDUP up more than 66% over the last 12 months. That suggests the recent weakness may be a normal pullback as investors step away from unprofitable companies.

In ThredUp’s case, add the caveat “yet” regarding profitability. The company operates an online consignment and thrift platform that is gaining traction with Gen Z — revenue rose 12.5% year-over-year in the most recent quarter.

ThredUp cites a GlobalData 2025 market survey forecasting the U.S. secondhand market’s gross merchandise value to grow at a compound annual growth rate (CAGR) of 9% through 2029.

Institutions own an impressive 89% of TDUP, and dollar-volume buying has outpaced selling roughly 2:1, while the number of buyers outnumbers sellers about 3:1. That said, short interest is near 17%, which can add short-term volatility.

The six-analyst consensus price target is $12.50, implying upside of more than 190% from the current price.

WThank you for subscribing to StockReport.com, our daily newsletter that highlights a new stock each day.

This email content is a paid sponsorship for Porter & Company, a third-party advertiser of StockReport.com and MarketBeat. 

If you have questions about your newsletter, please email our team at contact@stockreport.com.

If you no longer wish to receive email from StockReport.com, you can unsubscribe.

© 2006-2026 MarketBeat Media, LLC dba StockReport.com. All rights protected.
345 North Reid Place, Suite 620, Sioux Falls, South Dakota 57103-7078. USA..